U.S. Leisure Stock News

Soapbox and EBIN New York recently announced new and expanded hair care and styling assortments available in Sally Beauty stores and online, while Sally Beauty Holdings reported that its Fuel for Growth program delivered US$9 million in pre-tax benefits in the third quarter of 2026 and is targeting about US$45 million in savings for the fiscal year. The combination of exclusive in-store product launches and quantified cost savings gives investors a clearer view of how Sally Beauty Holdings...

Universal Health Services (NYSE:UHS) has agreed to acquire digital therapy provider Talkspace, creating a combined virtual and inpatient behavioral health platform. The transaction connects Talkspace’s online counseling services with UHS’s large network of psychiatric hospitals and outpatient facilities across the United States. Management plans to coordinate digital therapy with facility-based treatment to support smoother patient intake, step-down care, and ongoing follow-up. Universal...

Wix.com trades with a long, painful share price drop in the rear‑view mirror and a surprisingly strong value signal flashing green, which puts fresh focus on whether the current level reflects too much pessimism or not enough caution about the risks now hanging over the story. Over the past 5 years, Wix.com shareholders have seen the stock fall 63.8%, which leaves today’s valuation framed by heavy past losses rather than recent momentum. The push into AI driven website tools and related...

Albany International completed its review of the Amelia Earhart Drive facility in Salt Lake City, choosing to keep the site after securing new work and amended contracts with Sikorsky on CH-53K and Boeing on the 787 program, alongside issuing fourth quarter 2026 revenue guidance of US$325 million to US$335 million. The decision to retain a well capitalized aerospace composites facility, backed by revised contract terms that target reduced program risk and positive cash flow, signals a focus...

CVS Health has delivered a strong 49.8% gain over the past three years, yet its valuation checks still point to a stock that looks cheap on broad measures rather than fully priced in after the run. The 49.8% share price gain over three years suggests investors have already rewarded CVS Health for progress in the business, so the question is how much upside is left from here. Recent bullish analyst commentary that highlights recovery at Aetna and the potential return of share buybacks can...

Garmin recently rolled out redesigned Garmin Drive GPS units and an expanded JL Audio marine lineup, alongside new SmartDrive and GMI 40 marine systems, widening its hardware offering across road and sea. The cluster of launches concentrates capital and engineering effort into automotive and marine, suggesting a push to deepen ecosystem lock-in through integrated displays, sensors and audio on a single Garmin platform. We will now look at how Garmin's broader marine and automotive product...

Investor interest in Kiniksa Pharmaceuticals International (KNSA) picked up after the company reported sales figures that came in ahead of expectations, with the update coinciding with its appearance at the Wells Fargo healthcare conference on 9 September. Despite a modest pullback in the past week and month, with the 7 day share price return down 2.10% and the 30 day share price return down 2.00%, Kiniksa Pharmaceuticals International has seen strong momentum build over a longer window. The...

Vita Coco Company has seen coconut water unit sales average 15.2% growth over the past two years, with earnings per share rising 42.9% annually and free cash flow margins improving, which together have supported stronger profitability. The combination of rapid volume expansion and healthier cash generation gives Vita Coco more flexibility to fund product development, marketing, and international expansion without relying solely on external capital. We will now look at how Vita Coco Company’s...

Hercules Capital enters this valuation check with a strong 5 year share return set against market pricing that several models still flag as cheap, creating a clear question about how much upside is already reflected in the US$17.41 stock price. The Hercules Capital share price has delivered roughly 82.7% over 5 years, which puts long term holders in a solid position before considering what today’s valuation implies from here. Fresh capital raising progress at Hercules Adviser, including more...

Roblox (NYSE:RBLX) used its 2026 Developers Conference to unveil standalone app publishing, in-browser play and expanded 2D game support. The group introduced Roblox Wallet, aimed at speeding up creator payouts and centralising user spending across its platform. Management framed these tools as a way to simplify access to Roblox experiences for both players and developers. The shift to standalone apps, browser play, 2D games and Roblox Wallet is only part of the story for this platform. Our...

Merck and Moderna reported that their personalized mRNA cancer vaccine intismeran, used with Keytruda, delivered positive phase 3 results in resected late stage melanoma, showing statistically significant gains in recurrence free survival and survival without distant metastasis. The move toward a personalized oncology vaccine that may head into regulatory filings highlights how Moderna is trying to broaden its mRNA platform beyond seasonal respiratory shots and into more durable, potentially...

Alphatec Holdings stock has had a difficult year so far, with the share price down 49% year to date, yet several valuation checks suggest the current market price may sit well below what the underlying cash flows could justify. The year to date decline of 49% leaves the stock trading far below where it started 2026, which puts current pricing under closer scrutiny for potential mispricing. Future cash generation from Alphatec Holdings spinal surgery platform can support the current equity...

United Therapeutics has returned 148.5% over the past five years, yet recent months have been much flatter. This puts extra focus on whether the current price around US$497 still lines up with what the valuation checks imply. A 148.5% gain over five years points to a stock that has already rewarded patient holders, so fresh buyers need to think carefully about what is already priced in. The FDA review process for Tyvaso in idiopathic pulmonary fibrosis, along with the separate filing for...

Analog Devices stock has delivered strong multi year gains, yet current valuation checks suggest the shares lean expensive rather than offering clear value. After a powerful 5 year run, investors now face a pricing backdrop where enthusiasm and the broader valuation signals look out of sync. Over the past 5 years, Analog Devices has returned about 140%, which raises the question of how much of the business quality and AI story is already reflected in the share price. The agreed US$1.35b...

Mondelez International (MDLZ) has rolled out CHEWS in Canada, extending SOUR PATCH KIDS and MAYNARDS into soft, individually wrapped candies that target on the go snacking and gaming focused consumers. Mondelez International shares trade at US$62.44, with a year-to-date share price return of 16.38%. This contrasts with a 3-year total shareholder return that is down 5.33%, suggesting recent momentum has picked up after a weaker spell for long-term holders. Scan beyond Mondelez International...

A. O. Smith recently reported quarterly results with revenue slightly ahead of analyst estimates and full year EPS guidance above prior expectations, highlighting cost discipline and steady demand across its core water heating and treatment lines. The market reaction focused less on the earnings beat and more on A. O. Smith's slower revenue expansion versus peers, which underscores how relative growth expectations now influence how investors weigh its efficiency, product mix, and geographic...

Invesco stock has more than doubled over the past three years, yet its valuation checks send mixed messages, with an Excess Returns intrinsic value estimate pointing to upside while market multiples look rich. For anyone tracking the recent rally, the question is whether the market is ahead of itself or still underpricing the asset manager's earnings power. Invesco has returned 136.4% over three years, which puts recent strength front and center for anyone weighing fresh capital. New...

Old National Bancorp (ONB) has been in focus after appointing Katie Florig as President and Tom Weizenegger as Chief Investment Officer of its 1834 wealth division, reshaping leadership around its advisory and trust operations. Old National Bancorp’s recent leadership changes at 1834 come at a time when the share price has eased 5.24% over the past 30 days, while still showing a 13.79% year-to-date share price return and a 16.00% total shareholder return over one year. The 84.41% three-year...

e.l.f. Beauty stock has delivered very strong 5 year returns, yet today the valuation picture is pulled in different directions as a Discounted Cash Flow (DCF) estimate points to roughly fair pricing while traditional market multiples screen the shares as expensive. Over the past 5 years, e.l.f. Beauty has returned about 223.2%, which puts fresh focus on whether that performance already reflects most of the long term value in the business. New initiatives such as the Unglammy Valley...

Northrop Grumman (NYSE:NOC) is competing with Boeing for the U.S. Navy's sixth generation fighter jet contract, with a decision expected imminently. The program would define the Navy's next front line combat aircraft, with a multi decade production and support horizon. Winning the sixth generation fighter decision could influence Northrop Grumman's future role in U.S. military aviation programs. The outcome of the Navy's sixth generation fighter decision is important, but Northrop Grumman's...

Choice Hotels International has had a rough three years, with the share price down about 20.6%, yet the valuation checks still suggest the stock screens cheap on several fronts. Recent weakness now meets a high value score and an undervalued read on market multiples, which gives investors a very different signal from the price chart. Over the past three years, Choice Hotels International has declined about 20.6%, which points to a meaningful pullback that long term holders will be...

Allstate stock has delivered a very strong 147.9% gain over the past three years, yet current valuation checks still suggest the shares lean cheap rather than fully priced in. The 147.9% return over three years puts Allstate among the stronger performers in the insurance group. This raises the question of how much upside is already reflected in today's valuation. AM Best's affirmation of Allstate's A+ Financial Strength Rating can support confidence in future cash generation. However, any...

Agree Realty has delivered a solid 36.8% return over the past three years, yet the stock now screens as overvalued on market multiples and carries a low overall value score. For investors, that mix raises a simple question about Agree Realty stock today: whether the recent share gains leave much room for error. A 36.8% gain over three years points to a REIT that has already rewarded patient holders, which can limit upside if expectations stay high. Long leases and predictable rent streams...

Humana (NYSE:HUM) released new peer-reviewed research showing that integrated specialty pharmacy care affects Medicare Advantage drug access and costs. The Humana Healthcare Research study finds that this model leads to faster access to prescribed specialty medications for enrolled beneficiaries. The analysis reports lower out-of-pocket pharmacy spending for Medicare Advantage members using Humana's integrated specialty pharmacy services. The reported benefits from integrated specialty...